"The Bill & Melinda Gates Foundation and Wellcome announced the funding on 28 June. The vaccine candidate was developed by drug firm GSK, which has licensed it to the Gates Medical Research Institute."
#Vaccines #BillGates #Wellcome #GSK
https://www.nature.com/articles/d41586-023-02171-x
#Vaccines #BillGates #Wellcome #GSK
https://www.nature.com/articles/d41586-023-02171-x
Nature
Promising tuberculosis vaccine gets US$550-million shot in the arm
Nature - The candidate is moving to long-awaited phase III trials — if successful, it would be the first new jab against the disease in more than 100 years.